Home - Products - Others - Other Targets - HM-30181 mesylate monohydrate

HM-30181 mesylate monohydrate

CAS No. 2097125-58-9

HM-30181 mesylate monohydrate( —— )

Catalog No. M23945 CAS No. 2097125-58-9

HM-30181 mesylate monohydrate is an oral P-glycoprotein (P-gp) inhibitor, used to enhance the oral bioavailability of P-gp substrate drugs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 81 In Stock
5MG 115 In Stock
10MG 185 In Stock
25MG 309 In Stock
50MG 443 In Stock
100MG 644 In Stock
200MG 835 In Stock
500MG 1251 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HM-30181 mesylate monohydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    HM-30181 mesylate monohydrate is an oral P-glycoprotein (P-gp) inhibitor, used to enhance the oral bioavailability of P-gp substrate drugs.
  • Description
    HM-30181 mesylate monohydrate is an oral P-glycoprotein (P-gp) inhibitor, used to enhance the oral bioavailability of P-gp substrate drugs.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    P-gp?(P-glycoprotein)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2097125-58-9
  • Formula Weight
    784.84
  • Molecular Formula
    C39H40N6O10S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O.COc1cc2CCN(CCc3ccc(cc3)n4nnc(n4)c5cc(OC)c(OC)cc5NC(=O)C6=CC(=O)c7ccccc7O6)Cc2cc1OC.CS(=O)(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cha YJ, Lee H, Gu N, Kim TE, Lim KS, Yoon SH, Chung JY, Jang IJ, Shin SG, Yu KS, Cho JY. Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male Participants. Basic Clin Pharmacol Toxicol. 2013 Jul 6.
molnova catalog
related products
  • Burosumab

    Burosumab(KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.

  • S-99

    S-99 is a high purity chemical that targets ASK and is important for Immunology, Inflammation, Cancer research.

  • MGH-CP1

    MGH-CP1 is a potent and selective inhibitor TEAD palmitoylation. It exhibits dose-dependent and potent inhibition of TEAD2/4 auto-palmitoylation in vitro with IC50 of 710 nM and 672 nM, respectively.